Ayahuasca: Effects, Preparation & Ceremony

What Ayahuasca Is

Ayahuasca — also known as yagé, hoasca, daime, and by dozens of other regional names — is a psychoactive brew prepared from the Banisteriopsis caapi vine (the ayahuasca vine itself) and the leaves of Psychotria viridis (chacruna) or other DMT-containing plants. The vine contains beta-carboline alkaloids — primarily harmine, harmaline, and tetrahydroharmine — which are reversible monoamine oxidase inhibitors (MAOIs). These alkaloids inhibit the enzyme that would otherwise break down DMT in the digestive system before it reaches the bloodstream, allowing oral DMT to become psychoactive.

The brew has been used by Indigenous peoples of the Amazon basin — including the Shipibo-Conibo, Shuar, Yawanapi, and dozens of other nations — for centuries as a healing, divination, and ceremonial tool. Ayahuasca is not a recreational drug in its original context; it is a medicine administered by trained healers within carefully maintained ceremonial structures.

The brew is now used globally — in Indigenous and neo-Indigenous ceremonies, in syncretic religious traditions (Santo Daime, União do Vegetal), in retreat settings, and informally by individuals who prepare it themselves. This global diffusion has created significant ethical, cultural, and safety tensions that anyone engaging with ayahuasca should understand.

Pharmacology: How Ayahuasca Works

The active psychedelic compound in ayahuasca is N,N-dimethyltryptamine (DMT) — a tryptamine that activates serotonin 5-HT2A receptors, the primary target of all classical psychedelics. DMT is also endogenous in humans; it is found in trace amounts in human blood, urine, and cerebrospinal fluid, though its physiological function is not yet well understood.

Ordinarily, DMT taken orally is rapidly degraded by monoamine oxidase (MAO) enzymes in the gut and liver before it can cross the blood-brain barrier. The beta-carboline alkaloids in B. caapi inhibit MAO, allowing oral DMT to become bioavailable. This pharmacological synergy — the combination of a psychedelic compound and its enzyme inhibitor in a single brew — represents one of the most sophisticated examples of traditional botanical pharmacology known.

Effects and Experience

Ayahuasca ceremonies typically take place at night and last four to six hours. The brew is bitter and frequently produces nausea and vomiting — referred to in many traditions as "la purga" (the purge), understood not merely as a physical response but as a process of emotional and energetic release. Diarrhoea is also common.

Onset and arc

Effects begin 20–60 minutes after ingestion and reach peak intensity between 1–3 hours. The experience often involves multiple waves of intensity rather than a single continuous arc, and additional doses (called "medicina" or top-ups) are sometimes offered by the facilitating healer mid-ceremony.

Phenomenological character

Ayahuasca experiences are often described as more emotionally and psychologically directive than other psychedelics — more likely to produce confrontational encounters with psychological shadow material, relational trauma, or existential themes. Visions are common: complex geometric and figurative imagery, encounters with animals and beings, and narrative sequences that practitioners frequently experience as meaningful communications rather than random hallucinations.

Experiences of connection to the natural world, encounters with plant intelligence, and a felt sense of ecological embeddedness are among the most frequently reported themes in both qualitative research and practitioner accounts — making ayahuasca one of the most ecologically rich of all psychedelic substances from a phenomenological standpoint.

Ceremony and Container

In Indigenous and neo-Indigenous contexts, ayahuasca is administered within a ceremonial structure that has been refined over generations. The ceremony provides the container within which the experience unfolds — including the icaros (healing songs) sung by the curandero or curandera, the physical space (maloca), and the relationships of accountability between healer, community, and participant.

This ceremonial architecture is not decorative. Research by anthropologists and clinicians alike suggests that the ceremonial container is a significant determinant of the quality and therapeutic character of the experience — consistent with the set-and-setting principle operating at a collective rather than individual level.

When evaluating any ayahuasca retreat or ceremony, the key questions are: What is the lineage and training of the facilitating healer? What community accountability structures exist? What preparation and integration support is provided? Are Indigenous practitioners being equitably involved and compensated?

Research on Ayahuasca

Clinical research on ayahuasca has expanded significantly in the past decade, driven primarily by Brazilian and Spanish research groups. Key findings include:

Depression. A randomised controlled trial by Palhano-Fontes and colleagues (2019, Psychological Medicine) found significant antidepressant effects from a single ayahuasca session in treatment-resistant patients, with effects persisting at one and seven days. Effect sizes were large.

Neuroimaging. Studies show ayahuasca produces significant changes in default mode network connectivity, consistent with psilocybin findings. DMT specifically has been associated with a dramatic increase in neural complexity.

Nature-connectedness and ecological values. Qualitative and survey research consistently finds that ayahuasca experiences are associated with increased sense of connection to nature and motivation for pro-environmental behaviour — among the strongest effects in the psychedelic-ecology literature.

Critical Safety: MAOI Interactions

This section requires serious attention. The MAOI content of ayahuasca creates interaction risks that do not apply to other psychedelics. Some of these interactions are potentially fatal.

Allow a minimum of two weeks after stopping SSRIs before drinking ayahuasca — and only do so under medical guidance. Fluoxetine (Prozac) has a longer half-life and requires at least five weeks.

Risks and Contraindications

Beyond MAOI interactions, ayahuasca carries the same psychological contraindications as other classical psychedelics: personal or family history of schizophrenia spectrum disorders or bipolar I is a firm contraindication. Cardiovascular conditions warrant medical consultation given blood pressure fluctuations. Ayahuasca is not appropriate during pregnancy.

The intensity and duration of ayahuasca experiences — typically longer and more emotionally confrontational than psilocybin — means that psychological preparation is especially important. Attempting ayahuasca without adequate preparation, experienced facilitation, and a supported integration plan is inadvisable regardless of prior experience with other psychedelics.

Ethics, Sovereignty, and Informed Engagement

Ayahuasca presents some of the most significant ethical challenges in the contemporary psychedelic landscape. The global spread of ayahuasca has generated substantial revenue for Western retreat operators — while the Amazonian communities who developed and transmitted this knowledge frequently receive little benefit and face ongoing threats to their territories, cultural sovereignty, and linguistic survival.

Researchers Yuria Celidwen, Nicole Redvers, and others have articulated frameworks for ethical non-Indigenous engagement: genuine relationship with and compensation for Indigenous practitioners, refusal to participate in extractive tourism models, support for Indigenous land rights, and epistemic humility about what one does and does not understand about the tradition being engaged with.

None of this prohibits non-Indigenous people from working with ayahuasca. It does mean that doing so thoughtfully requires engagement with these questions rather than consumption of a product.

Frequently Asked Questions